A method of treating skin conditions using genetically modified microorganisms.
Genetically engineered Corynebacterium strains in topical probiotic compositions sustainably express SOD and CAT, overcoming the degradation issues of conventional creams to effectively combat oxidative stress in the skin.
JP2026518351APending Publication Date: 2026-06-05RESVITA BIOINCORPORATED
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- RESVITA BIOINCORPORATED
- Filing Date
- 2024-05-24
- Publication Date
- 2026-06-05
Smart Images
Figure 2026518351000001_ABST
Abstract
This disclosure relates to compositions and methods using genetically modified bacteria that express superoxide dismutase (SOD) and catalase enzymes to reduce oxidative stress in the skin, and can be used for various skin conditions. In some embodiments of this disclosure, the genetically modified bacteria are Gram-positive bacteria, for example, of the genus Corynebacterium.
Need to check novelty before this filing date? Find Prior Art